1. Home
  2. BWEN vs IRD Comparison

BWEN vs IRD Comparison

Compare BWEN & IRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BWEN
  • IRD
  • Stock Information
  • Founded
  • BWEN N/A
  • IRD 2018
  • Country
  • BWEN United States
  • IRD United States
  • Employees
  • BWEN N/A
  • IRD N/A
  • Industry
  • BWEN Industrial Machinery/Components
  • IRD
  • Sector
  • BWEN Industrials
  • IRD
  • Exchange
  • BWEN Nasdaq
  • IRD NYSE
  • Market Cap
  • BWEN 33.7M
  • IRD 38.8M
  • IPO Year
  • BWEN N/A
  • IRD N/A
  • Fundamental
  • Price
  • BWEN $1.62
  • IRD $0.95
  • Analyst Decision
  • BWEN Strong Buy
  • IRD Strong Buy
  • Analyst Count
  • BWEN 3
  • IRD 2
  • Target Price
  • BWEN $4.50
  • IRD $7.00
  • AVG Volume (30 Days)
  • BWEN 72.0K
  • IRD 184.8K
  • Earning Date
  • BWEN 05-13-2025
  • IRD 05-23-2025
  • Dividend Yield
  • BWEN N/A
  • IRD N/A
  • EPS Growth
  • BWEN N/A
  • IRD N/A
  • EPS
  • BWEN 0.05
  • IRD N/A
  • Revenue
  • BWEN $143,136,000.00
  • IRD $10,992,000.00
  • Revenue This Year
  • BWEN $8.78
  • IRD $22.00
  • Revenue Next Year
  • BWEN $10.05
  • IRD $100.89
  • P/E Ratio
  • BWEN $32.40
  • IRD N/A
  • Revenue Growth
  • BWEN N/A
  • IRD N/A
  • 52 Week Low
  • BWEN $1.41
  • IRD $0.65
  • 52 Week High
  • BWEN $4.65
  • IRD $2.18
  • Technical
  • Relative Strength Index (RSI)
  • BWEN 56.80
  • IRD N/A
  • Support Level
  • BWEN $1.49
  • IRD N/A
  • Resistance Level
  • BWEN $1.72
  • IRD N/A
  • Average True Range (ATR)
  • BWEN 0.07
  • IRD 0.00
  • MACD
  • BWEN 0.00
  • IRD 0.00
  • Stochastic Oscillator
  • BWEN 56.52
  • IRD 0.00

About BWEN Broadwind Inc.

Broadwind Inc is a precision manufacturer of structures, equipment and components for clean technology and other specialized applications. The company provide technologically high value products to customers with complex systems and stringent quality standards that operate in energy, mining and infrastructure sectors, in the United States of America. It capabilities include heavy fabrications, welding, metal rolling, coatings, gear cutting and shaping, gearbox manufacturing and repair, heat treat, assembly, engineering and packaging solutions. It operates through four operating segments namely Heavy Fabrications, Gearing, Industrial Solutions and Corporate.

About IRD OPUS GENETICS INC

Opus Genetics Inc is a clinical-stage ophthalmic biopharmaceutical company developing therapies to treat patients with inherited retinal diseases (IRDs) and therapies to treat patients with other retinal and refractive disorders. The pipeline includes adeno-associated virus (AAV)-based gene therapies that address mutations in genes that cause different forms of bestrophinopathy, Leber congenital amaurosis (LCA), and retinitis pigmentosa. The pipeline also includes Phentolamine Ophthalmic Solution 0.75%, a non-selective alpha-1 and alpha-2 adrenergic antagonist to reduce pupil size, and APX3330, a novel small-molecule inhibitor of Ref-1 to slow the progression of non-proliferative diabetic retinopathy.

Share on Social Networks: